Background Albuminuria predicts end-organ dysfunction in the general population. Its detection in people living with HIV (PLWH) is understudied, despite their heightened risk for end-organ dysfunction. We assessed agreement between albumin‒creatinine ratio (ACR) and urine albumin (UA) tests for albuminuria in a cohort of PLWH in Botswana, where females are more affected by HIV than males. Methods We used cross-sectional convenience sampling to enrol 1533 virally suppressed adults aged ≥ 21 years who were receiving antiretroviral therapy (ART) in Gaborone, Botswana. We measured urine creatinine levels using a colorimetric assay (Jaffe method) and UA levels using an immunoturbidimetric assay. The UA was used due to it being less costly and simpler, making it more feasible for routine use in resource-limited settings compared to the ACR. We defined albuminuria as 30mg/g versus 30 mg/Lusing ACR and UA levels respectively. Agreement between the two tests was assessed using Cohen’s kappa for the entire cohort and then separately by sex groups. The optimal UA cutoff point that matched the sex-specific ACR was assessed using Youden’s J index. Results The ACR detected similar proportion of participants with albuminuria as UA test (17.1% versus 17.6%). There was moderate agreement in the detection of albuminuria using the ACR versus UA test in the entire cohort, among males and females with Kappa statistics of 0.71 (95% CI: 0.67, 0.76; P<0.001), 0.74 (95% CI: 0.68, 0.80; P<0.001), and 0.68 (95% CI: 0.60, 0.76; P<0.001) respectively. Using Youden’s J, the optimal cut points for UA levels were 17.9 mg/L (sensitivity=88.9%, specificity=87.3%, AUC=0.94), 25.0 mg/L (sensitivity=90.4%, specificity=90.1%, AUC=0.94) and 15.1 mg/L (sensitivity=89.7%, specificity=87.5%, AUC=0.94) for the entire cohort, males only and females only, respectivel

Projects

Currently no objects available

Currently no objects available